NCT06936293Completed
Effects of Mindfulness Meditation on Hemodialysis Patients
Effects of Mindfulness Meditation on Quality of Sleep, Perceived Stress, Serum Cortisol, and C-reactive Protein in Hemodialysis Patients
Source: ClinicalTrials.gov · Last updated 20 Apr 2025
Brief summary (registry, in English)
Objective: This study aimed to examine the effects of mindfulness meditation on the quality of sleep, perceived stress, serum cortisol, and C-reactive protein in end-stage renal disease patients undergoing hemodialysis. Methods: An experimental study with a repeated measures design was conducted among 56 patients with end-stage renal disease undergoing hemodialysis at Jahra Hospital, Kuwait, between September 2024 and February 2025. The patients were randomly assigned to the experimental (n = 28) and control groups (n = 28). The experimental group participated in 30-minute mindfulness meditation sessions (three sessions a week for eight weeks) held during their hemodialysis sessions; the participants in the control group were instructed to sit with their eyes closed and relax for 30 min three times a week for eight weeks during hemodialysis sessions. The dependent variables of both groups were measured at baseline (T0), middle of intervention (T1), and end of intervention (T2) using the Pittsburgh Sleep Quality Index (PSQI), Perceived Stress Scale (PSS), and Biomedical markers (Access Cortisol Assay and CRP reagent).
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 56 (actual)
- First submitted
- 3 Apr 2025
- Start date
- 15 Sept 2024
- Primary completion date
- 15 Nov 2024
- Lead sponsor
- University of Jordan
- Diseases
- Chronic kidney disease
- NCT number
- NCT06936293
What you commit to
- Study type: Interventional
- Participants enrolled: 56
- From 15 Sept 2024 to the primary completion date, 15 Nov 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Regularly consuming psychopharmacological drugs to reduce stress and improve sleep.
- Participating in other psychological therapies at the time, or had prior formal training in mindfulness methods or a current meditation practice.
Other
- Patients with cognitive dysfunction or mental retardation.
- Suffering from rheumatoid arthritis.
- Using a hearing aid.
Who the study is looking for
- Patients with ESRD who underwent hemodialysis thrice weekly for a minimum of one year.
- Were at least 18 years old.
- Having a urea reduction rate greater than 65% or Kt/V greater than 1.2 in the past month.
- Possessing Arabic literacy skills.
- Agreed to participate.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Dialysis center at Jahra Governmental Hospital Coordinator of this site? Confirm its status | Al Jahra | Kuwait | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.